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1 Introduction
Group B streptococci (GBS) are a major cause of
neonatal infection and contribute considerably to
perinatal mortality in the Western world [16]. The
early onset disease, occurring within a few days
of life, is usually acquired by vertical transmission
from the mother; whereas, in late onset infection,
a delayed acquisition, e.g. nosocomial, has been
suggested [1].
Among parturients, 15 — 35% are colonized with
GBS in the urogenital tract [1]. Prematurity and/
or prolonged rupture of membranes increase the
risk of an infant of a colonized mother to contract
infection [6]. Low maternal levels of type-specific
IgG to GBS also increase the possibility for sep-
ticemia [4].
GBS have also been the predominant cause of
early onset septicemia in our neonatal intensive
care unit, as previously reported [13]. Since 1975,
all cases of GBS-septicemia have been prospec-
tively registered in the department. Since 1981,
women who have previously given birth to an
infant contracting GBS-septicemia have under-
gone carfeul surveillance during subsequent preg-
nancies using a special prevention program [10].
In the present study we have reviewed all cases of
early onset GBS-septicemia during the time period
of 1975 to 1986 with special regard to perinatal
risk factors. The outcome of a subsequent preg-
nancy in mothers of infants with GBS-septicemia
has also been studied in order to evaluate the
prevention program.
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2 Material and methods
2.1 Definitions
Septicemia was defined by one positive blood cul-
ture with growth of GBS combined with clinical
signs of infection and early onset septicemia oc-
curred within the first five days of life.
2.2 Infants
All infants with early onset GBS-septicemia born
between January 1975 and December 1986 at the
Karolinska Hospital are included in the study.
These neonates were all admitted to the neonatal
intensive care unit (NICU) at the hospital. Thirty-
two thousand one hundred and forty-three infants
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were born alive in the hospital during the period,
and 40 of them contracted early onset GBS-sep-
ticemia. Among these infants were 37 singletons,
one of a twin pair, and both infants of another
twin pair. Late onset GBS-septicemia was diag-
nosed in two infants born at the hospital and cared
for in the NICU during the time of the study.
Since April 1982 no infants have been readmitted
to the hospital after discharge from maternity
wards.
2.3 Mothers
The obstetrical records of the 41 mothers were
reviewed retrospectively. Obstetrical data of the
39 mothers to the infants with early onset GBS-
septicemia are presented in table I. Among the
women, two had twin pregnancies, two had dia-
betes mellitus and two had mild pregnancy-in-
duced hypertension. Three of the women received
cerclage, which in one of whom was due to a twin
pregnancy. Labor was induced in six of the pa-
tients, in four of whom because of postmaturity.
Previous obstetrical history was also investigated.
One of the women had a previous late intrauterine
fetal death, another had an earlier history of three
miscarriages.
One of the two mothers whose infants contracted
late onset GBS-septicemia was delivered by cesar-
ean section, the other had a preterm vaginal de-
livery.
2.4 The subsequent pregnancy
During the subsequent pregnancy(ies) (one to
three) the mothers were referred to a special pre-
natal clinic. In all, 24 infants were born to 17 of
the mothers up to December 1986. One of these
infants was born in another hospital. Cultures
were obtained from the urethra and cervix once
weekly after the 28th week of pregnancy. If colo-
nized with GBS, the mother was given penicillin
V orally l g twice daily during the remaining part
of pregnancy, followed by intravenous bensyl pen-
icillin 3 g every sixth hour during labor until de-
livery. Furthermore, cardiotocography (CTG) reg-
istration was performed weekly as well as cervical
palpation.
The neonates of mothers who were GBS-carriers
and/or had been treated with antibiotics during
delivery were all admitted to the NICU for sur-
veillance. They were given bensyl penicillin intra-
venously every twelve hours for 48 to 96 hours.
The treatment was discontinued if blood cultures
were negative and clinical and laboratory signs of
infection were absent.
2.5 Laboratory methods
From each infant cultures were taken from the
external auditory duct, umbilicus, nasopharynx
and throat on arrival to NICU. When infection
was suspected from the clinical picture, cultures
were obtained from blood and cerebrospinal fluid
(CSF). Urethra and cervical specimens from the
mothers were cultured for potentially pathogenic
bacteria (Enter obacteriaceae, beta-hemolytic
streptococci, staphylococci, Listeria, Hemophilus
influenzae) using routine bacteriological methods
[18]. These specimens were also processed using a
selective broth medium [3].


























































Age; mean (range) 27.8 (21-44) years 24.8 (19-37) years
< 37 weeks gestation
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Blood for culture was drawn from a peripheral
vein. The blood specimens were inoculated into a
set of two culture bottles containing Brain Heart
Infusion Agar (Difco, USA) slants with a p-amino-
benzoic-acid (PABA) and meat infusion broth
with PABA and penicillinase. After 1977 typing
of GBS was performed as previously described [8].
Blood specimens from 27 of the 41 mothers whose
infants had contracted GBS-septicemia were also
available. The specimens were taken by venipunc-
ture as soon as the diagnosis was made in the
infant. Antibodies to GBS types I a, I b, II and III
were measured with radiolabelled protein A [10].
In brief, the serum to be tested was absorbed with
a GBS strain without type-specific antigens. The
absorbed sera were mixed with a standardized
suspension of the type of GBS to which antibodies
were to be measured. Each specimen was tested in
duplicate and the difference between a pair of
duplicates for a given type was not allowed to
exceed 10% of their mean value. The reference
intervals for each type presented in the results
represents the range obtained with sera from 100
healthy pregnant women.




where H = the highest radioactive count obtained
with the 100 reference sera, L = lowest value, and
P = the patient's value. C-reactive protein was
detected by latex agglutination (RapiTex CRP,
Behring, Behringwerke AG, FRG). When positive
(> 6 mg/1) the serum was retested by a quantita-
tive immunodiffusion method (LC-Partigen, Behr-
ing, Behringwerke AG, FRG). GBS antigen in
serum was detected by latex agglutination (Well-
cogen Strep B, Wellcome, England). Blood cell




The incidence of early onset GBS septicemia dur-
ing the period was 1.24 per 1000 live births. The
annual variation is shown in figure 1, demonstrat-
ing a marked top in 1981 in connection with an
abrupt increase in the number of deliveries in the
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Figure 1. Incidence of early onset group B streptococcal
(GBS) septicemia in infants born at the Karolinska Hos-
pital 1975-1986.
3.2 Obstetrical data in the early onset cases
(table I)
Twelve (31%) of the 39 mothers were delivered by
cesarean section compared to an over-all incidence
of 14% (p < 0.01; Chi Square Test, one tail with
Yates correction). The indications for cesarean
section were preterm labor and breech position
(n = 5), slow progress of labor (n = 3), fetal as-
phyxia (n = 3) and placenta previa (n = 1). Re-
markably, 10 (26%) of the women were delivered
by vacuum extraction, compared to a usual fre-
quency of 12% (p < 0.01; Chi Square Test, one
tail with Yates correction). Fever (> 38 °C) was
registered in nine (23%) of the mothers before,
during or after delivery. Eight (21%) of the
women, five of whom were delivered by vacuum
extraction and three by cesarean section, had clin-
ical evidence of endometritis during the puerper-
ium. Three women who were delivered by cesarean
section contracted a wound infection.
3.3 Clinical and laboratory findings in the infants
with GBS septicemia (table II)
Early onset septicemia: Twenty-two (55%) of the
40 infants with early onset septicemia were pre-
term. Nineteen (48%) were born after prolonged
rupture of membranes defined as > 12 hours be-
tween the rupture of membranes and delivery. The
corresponding figures of prematurity and pro-
longed rupture of membranes for all deliveries in
the hospital were 7.2% and 12%, respectively.
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Taken together, prematurity and/or prolonged
rupture of membranes were present in 33 (83%)
of the infants and in all with a fatal outcome.
Twenty-six (67%) of the infants had onset of
symptoms within six hours after birth. Pulmonary
involvement with respiratory distress and radio-
logical changes corresponding to pneumonia or
hyaline membrane disease (HMD) were seen in 31
(79%). Twelve (30%) of the infants had a fulmi-
nant course with shock.
One of the preterm infants had evidence of per-
sistent fetal circulation. Whereas all CSF-speci-
mens were culture negative, GBS was recovered
from one infant at day 8 of life in specimens from
the hip joint. This infant, treated with penicillin
since the second day of life, showed osteomyelitis
clinically and radiologically.
A total leukocyte count of < 5 χ 109/L was seen
in six of the 35 (17%) infants, whereas a neutrophil
count of < 1 χ 109/L was seen in three of 34 (9%).
Five of 35 (14%) infants had platelet counts of
< 100 χ 109/L. Initial C-reactive protein above
15 mg/L was found in 14 of 27 (52%) infected
infants in whom this test was performed. GBS-
antigen in serum was detected in five of the nine
tested (55%) infants.
The fatality rate was 22%. Seven (32%) of the
preterm infants died versus two (11 %) of the term
infants (N. S. p > 0.05).
Late onset septicemia: Both mothers were GBS-
carriers and were treated with antibiotics during
delivery due to fever. Both infants were diagnosed
as having GBS-pneumonia (without septicemia)
during the neonatal period. One infant born at
term was readmitted at six weeks of age with signs
of meningitis and a CSF positive for GBS. The
other infant born at 26 weeks gestation with a
birth-weight of 907 g has an episode with GBS-
septicemia at six weeks of age.
Bacteriological and immunological findings: The
GBS-strains from 30 of the infants with early onset
disease were available for serotyping: 14 (47%)
belonged to type III, 6 (20%) each to types la
and Ib, and 4 (13%) to type II. The strains from
seven of the nine fatal cases were serotyped: 4
belonged to I a, and 3 to III. The late onset cases
were caused by serotype II (meningitis) and Ib
(not present in CSF). Among the 27 mothers from
whom sera were available, 24 (89%) were very
low in serum levels of IgG antibodies against the
infecting type of GBS (figure 2) compared to
mothers colonized with GBS but giving birth to
healthy infants. Three mothers had normal levels.
Among the latter three, one was delivered pre-
maturely in week 29 (patient No. 1; figure 2), and
another with forceps after 34 hours of ruptured
membranes (patient No. 2; figure 2). The third
was delivered at term without any characteristic
abnormalities except for diabetes mellitus (patient
No. 3; figure 2).
Outcome of new pregnancies in mothers to infants
with GBS-septicemia: In all, 17 mothers went
through 24 new pregnancies. In 11 pregnancies,
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Figure 2. Determination of antibodies against surface
antigens of group Β streptococci in sera from mothers
of infants contracting neonatal septicemia. Each serum
was tested against the infecting type. Results were ex-
pressed according to the formula
? ~ L χ 100%Η — L
where H = the highest radioactive count obtained with
100 sera from normal women, L = the lowest value,
and P = the patient's value. la denotes antibodies
against type I a group B streptococci etc. 1, 2 and 3 refer
to patients commented in the results.
the mothers were colonized with GBS. Seven re-
ceived penicillin orally starting at week 28 and
three from later in pregnancy, when a colonization
was detected. Cultures from the urogenital tract
obtained during oral penicillin treatment revealed
occasional GBS in three, coliforms in two, Kleb-
siella in two and combined Klebsiella and Esche-
richia coli in one patient.
Four of the infants were born preterm (table III).
One of these born at another hospital at 25 weeks'
gestation with a birth weight of 700 g died from
GBS-septicemia; neither the infant nor the mother
received antibiotics.
Three infants presented with pulmonary maladap-
tation (PMA) syndrome. In the remaining infants
born after prophylaxis the neonatal course was
uneventful.
One of the infants of mothers without antibiotic
treatment was colonized with GBS at one site at
birth, whereas, four (40%) of the infants in the
prophylaxis group were colonized with gram-neg-
ative rods at one or more sites. Cultures revealed
coliforms in one, E. coli in two and combined
Klebsiella and E. coli in one infant.
Table ΠΙ. Obstetric and infant data in 24 pregnancies of
17 mothers with a previously born infant contracting
GBS-septicemia
No.
Pregnancies (n = 24)
Preterm delivery




Infants (n = 24)
Gestation < 37 weeks
Birth weight < 1500 g





























Time between pregnancies varied between 15 and 50
months (mean 2 years)
Sera were available from 12 women giving birth
to 15 "new" infants, and sera were again obtained
during the "new" pregnancy from 11 women. Nine
of the 11 showed unchanged serum levels during
the "new" pregnancy. Two patients with low an-
tibody levels at the pregnancy resulting in an in-
fant with GBS septicemia showed normal levels
the following pregnancy. Both these were delivered
at term in the "new" pregnancy but prematurely
in the previous.
4 Discussion
The present Swedish panorama of GBS-septicemia
differed from that reported from the Southern part
of USA. Late onset GBS-septicemia constituted
only 5% (2/42) of the registered infections whereas
dominance of the late onset form was reported
from Alabama [21], Dallas [15] and Houston [2].
Furthermore, our two late onset infections were
caused by serotypes I b and II, in contrast to the
total dominance of type III reported from the USA
[2]. The over-all type distribution was more con-
sistent with the situation in Denmark [17], Holland
[7] and Chicago [14].
It has been suggested that late onset GBS-septi-
cemia is due to nosocomial spread of GBS [18]. It
is tempting to speculate that the difference be-
tween the present results and those reported from
J. Perinat. Med. 16 (1988)
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the Southern USA can be explained by differences
in hospital hygienic procedures, but could also be
explained by differences in colonization rate. In a
Swedish study the rate of infant carriage of GBS
at discharge from the maternity unit was 13% [11]
whereas a Texas study revealed 65% colonization
[20]. Late onset meningitis might be a disease
which is partially preventable by hygienic meas-
ures. This view was further corroborated by the
finding that the two mothers giving birth to infants
acquiring late onset GBS-septicemia both received
antibiotics during the delivery. Since both were
GBS-carriers, the treatment may have interrupted
a vertical transmission of GBS during delivery
while a transmission from mother to infant then
could have occurred later. In other words, the two
late onset infections may represent "converted"
early onset infections.
The attack rate of GBS-septicemia has been re-
ported to 0.02-0.6 per 1,000 live births in Europe
[19]. The present result of 1.24 per 1,000 live births
cannot be explained by admittance of diseased
infants from other clinics since only babies born
at the hospital were included.
An encouraging finding was that as many as 83%
of the early onset GBS infections — and all fatal
infections — belonged to one or both of the two
risk groups prematurity and prolonged rupture of
the fetal membranes. Combined with screening for
maternal carriage of GBS during pregnancy, se-
lective prophylaxis during delivery with antibiotics
to these risk groups can prevent early onset sep-
ticemia [12]. A simple screening method suitable
for use at antenatal clinics was recently described
[9]. Although 4 — 8 hour methods for GBS screen-
ing are available [22] screening at the obstetrical
ward cannot be recommended because it will delay
the treatment 4 — 8 hours. A high proportion of
the infants (67%) showed symptoms within six
hours after birth.
The finding that mothers with preterm delivery
also showed low levels of IgG antibodies against
the infecting type has not been reported previously
to our knowledge. This raised the question
whether low levels of IgG to GBS combined with
urogenital carriage of GBS may induce premature
delivery. In support of this view, an association
between GBS-carriage and prematurity was re-
cently reported [20]. As many as 55% of the in-
fants were born before pregnancy week 37 among
the 40 early onset infected babies whereas only
two of 10 receiving penicillin prophylaxis in the
"new" pregnancy were delivered prematurely. In
this context it was of interest that penicillin treat-
ment recently was shown to prevent premature
rupture of membranes in GBS carriers (A. C.
Thomsen, personal communication).
The effect of the prevention program designed for
"new" pregnancies was difficult to ascertain from
the present study. Remarkably one mother gave
birth to a "new" baby in pregnancy week 25 ac-
quiring GBS-septicemia.
In conclusion, the present panorama of GBS-sep-
sis closely resembled that reported from Chicago
[6]. The majority of our GBS-sepsis cases appear
to be preventable by combined screening during
pregnancy and selective antibiotic prophylaxis.
Summary
All cases of early onset group B streptococcal (GBS)
septicemia in infants born at Karolinska Hospital 1975 —
1986 were reviewed. GBS-septicemia was diagnosed in
40 infants within the first five days of life. The incidence
was 1.24 per 1000 births. Fifty-five percent of the infants
were preterm and 48% were born more than or equal
to 12 hours after rupture of membranes. Prematurity
and/or prolonged rupture of membranes were present in
83% of all neonates with fatal outcome. Case fatality
was 22%. Deliveries by both cesarean section (31%) and
vacuum extraction (26%) were increased in the mothers
when compared to an overall incidence of 14 and 12%
(p < 0.01). Twenty-four (89%) of 27 mothers had low
type specific IgG antibodies against the infecting GBS-
serotype. Late onset GBS-septicemia was diagnosed in
only two infants during the period.
Seventeen mothers went through 24 subsequent preg-
nancies. In 11 of those the mothers were colonized with
GBS and 10 received penicillin prophylaxis during preg-
nancy and/or delivery. None of the infants born after
prophylaxis were colonized with GBS. Two were born
prematurely and all had an uneventful course; whereas
one infant delivered at 26 weeks gestation of a colonized
untreated mother died of GBS-septicemia. Screening of
parturients at risk and selective antibiotic prophylaxis
may help to prevent early onset GBS-septicemia.
Keywords: Group B streptococcus, neonatal septicemia, perinatal risk factors.
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Zusammenfassung
Neonatale Sepsis bei B-Streptokokken-Infektion — peri-
natale Risikofaktoren und Bedeutung bei nachfolgenden
Schwangerschaften
Wir berichten über alle Fälle von früh einsetzender Sep-
tikämie durch Streptokokken der Gruppe B (GBS) bei
Kindern, die während des Zeitraums 1975 — 1986 im
Karolinska-Hospital geboren wurden. Die Diagnose
wurde bei 40 Kindern innerhalb der ersten fünf Lebens-
tage gestellt, was einer Inzidenz von 1.24 auf 1000 Ge-
burten entspricht. 55% der Kinder waren Frühgeborene
und bei 48% lag der Blasensprung 12 oder mehr Stunden
zurück. Die Mortalität betrug 22%, davon waren 83%
prämatur und/oder nach länger zurückliegendem Bla-
sensprung geboren. Sowohl Sektiones (31%) wie auch
Vakuumextraktionen (26%) waren verglichen mit dem
Gesamtkollektiv häufiger (14% bzw. 12%; p < 0.01). 24
der 27 Mütter (= 89%) hatten niedrige typenspezifische
IgG-Antikörpertiter gegen den infizierenden GBS-Se-
rotyp. Eine spät einsetzende GBS-Septikämie wurde in
dem oben genannten Zeitraum lediglich in 2 Fällen dia-
gnostiziert.
17 Mütter durchliefen 24 weitere Schwangerschaften. Bei
11 dieser Frauen wurden GBS-Kolonien nachgewiesen
und 10 erhielten während der Schwangerschaft und/oder
der Entbindung eine Penicillin-Prophylaxe. Bei keinem
der Neugeborenen nach Prophylaxe konnten GBS-Ko-
lonien nachgewiesen werden. 2 Kinder waren Frühge-
borene mit unauffälligen Verläufen. Ein Kind von einer
unbehandelten, infizierten Mutter wurde in der 26. Wo-
che geboren und starb an einer GBS-Septikämie. Wir
meinen, daß eine Screening bei Risikopatientinnen und
eine selektive antibiotische Prophylaxe bei der Präven-
tion der früh einsetzenden GBS-Septikämie sinnvoll sein
könnten.
Schlüsselwörter: Neonatale Sepsis, perinatale Risikofaktoren, Streptokokken der Gruppe B.
Resume
Septicemies neonatales a stretocoque du groupe B facteurs
de risque perinatal et avenir des grossesses ulterieures
On a passe en revue tous les cas de septicemie ä strep-
tocoque du groupe B (GBS) ä debut precoce chez les
enfants nes ä Fhopital Karolinska de 1975 ä 1986. Chez
40 enfants le diagnostic de septicemie a GBS a ete porte
au cours des cinq premiers jours de vie. Uincidence est
de 1,24 pour 1000 naissances. 55% des enfants etaient
des prematures et 48% sont nes 12 Heures ou plus apres
la rupture des membranes. Pour 83% des nouveaux-nes
ayant eu une evolution fatale, il existait une prematurite
et/ou une rupture prolongee des membranes. La mor-
talite etait de 22%. Chez les meres les taux de cesariennes
(31%) et de ventouses (26%) etaient superieurs au taux
globaux 14% et 12% (p < 0,01). Vingt quatre (89%) des
27 meres etaient porteuses d'anticorps IgG peu speci-
fiques contre les serotypes des GBS responsables de
Finfection. Ce n'estque chez deux enfants seulement au
cours de cette periode que a diagnostique une sep-
ticemie ä GBS de debut tardif.
17 meres ont eu 24 nouvelles grossesses. II meres etaient
porteuses de GBS et 10 ont regu une penicillino-prophy-
laxie au cours de la grossesse et/ou de Taccouchement.
Aucun enfant ne apres prophylaxien a ete colonise par
le GBS. 2 sont nes prematuremment et tous ont eu des
suites simples, alors qu'un enfant ne d'une mere porteuse
et non traitee ä 26 semaines de gestation est mort d'une
septicemie ä GBS. Le depistage des patientes a risque et
une prophylaxie antibiotique selective pourraient aider
ä la prevention des septicemies a GBS ä debut precoce.
Mots-cles: Facteur de risque perinatal, septicemie neonatale, stretocoque du groupe B.
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